Retinoid therapy of pigmentary disorders
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Topical retinoids such as all-trans-retinoic acid (RA), 13-cis-retinoic acid (isotretinoin), retinol, retinaldehyde, tazarotene, and adapalene have been shown to improve dyspigmentation of photodamaged skin including mottling and actinic lentigines. RA monotherapy has also been demonstrated to improve melasma and postinflammatory hypermelanosis. Furthermore, RA in combination with hydroquinone or 4-hydroxyanisole, or azelaic acid increases the potency of depigmenting agents for the treatment of melasma, actinic lentigines, and postinflammatory hypermelanosis. The basic mechanisms underlying these effects are not completely identified. Topical retinoids stimulate the cell turn-over of epidermal keratinocytes and promote a decrease in melanosome transfer and a rapid loss of melanins via epidermopoiesis. Topical retinoids are also involved in the control of cell differentiation. Retinoid-induced changes in the stratum corneum and the permeability barrier may also facilitate the penetration of depigmenting agents in the epidermis and increase their bioavailability, leading to increased depigmentation. In addition, several in vitro studies demonstrate that cis and trans-retinoic acid inhibit UV-B stimulated melanogenesis in term of tyrosinase activity and melanin synthesis. It is likely that topical retinoids modulate epidermal melanin count via a direct action on melanocytes and epidermal keratinocytes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Draelos, Z. D. (2005) · Dermatologic Surgery · doi:10.1111/j.1524-4725.2005.31723 · Cited by 22 · cited 1×
“3% stabilized ROL in an emollient vehicle is now available (29).”
Background
Cited by
Melasma: A comprehensive update
Sheth, V. M., & Pandya, A. G. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.12.046 · Cited by 377
Facial hyperpigmentation: causes and treatment
Vashi, N. A., & Kundu, R. V. (2013) · British Journal of Dermatology · doi:10.1111/bjd.12536 · Cited by 162
Skin whitening cosmetics: feedback and challenges in the development of natural skin lighteners
Burger, P., Landreau, A., Azoulay, S., Michel, T., & Fernandez, X. (2016) · Cosmetics · doi:10.3390/cosmetics3040036 · Cited by 152
Shimoda, H., Tanaka, J., Shan, S.-J., & Maoka, T. (2010) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2010.01139.x · Cited by 152
Rossetti, D., Kielmanowicz, M. G., Vigodman, S., Hu, Y. P., Chen, N., Nkengne, A., Oddos, T., Fischer, D., Seiberg, M., & Lin, C. B. (2011) · International Journal of Cosmetic Science · doi:10.1111/j.1468-2494.2010.00588.x · Cited by 75
“Clinically, ROL was shown to enhance keratinocyte proliferation [23–25], to increase the production of collagen [23, 26], and to reduce the formation and the pigmentary levels of dyspigmentation [27].”
Background
Metadata
- Authors
- Ortonne, J.-P.
- Venue
- Dermatologic Therapy
- Publisher
- Hindawi Limited
- Published
- 2006-09
- Volume
- 19
- Issue
- 5
- Pages
- 280-288
- ISSN
- 1396-0296 (ISSN-L)
- 1529-8019
- OpenAlex
- W2137391819
- Cited by
- 134
- References
- 1
- FWCI
- 1.50
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.